[Bencyclan's effects "in vitro" on fibrinolysis (author's transl)].
The eventual fibrinolytic activity of Bencyclan (N-3-(1-benzil-cicloeptil-ossi)-propil-N-N-dimetil-amino-fumarato-acid) has been studied in vitro. The presence of eventuals FDP has been calculated through the Staphylococcal clumping test (SCT), by previous incubation of blood-samples with scalar concentrations of Bencyclan. No increase in the fibrinolytic activity with regard to the incubation of samples with the above-mentioned substance has been noticed.
D001537:Bencyclane / Q000494:pharmacology*; D003508:Cycloheptanes / Q000494:pharmacology*; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques
D003508:Cycloheptanes; D001537:Bencyclane
Effetti "in vitro" del Bencyclan sulla fibrinolisi.